Reducing GC bias in DNA sequencing using nucleotide analogs

• US 9,499,863 B2
• Filed: 09/16/2013
• Issued: 11/22/2016
• Est. Priority Date: 12/05/2007
• Status: Active Grant

• Current Assignee: Complete Genomics Incorporated (BGI Genomics Co., Ltd.)
• Original Assignee: Complete Genomics Incorporated (BGI Genomics Co., Ltd.)
• Inventors: Drmanac, Radoje, Peters, Brock A., Alexeev, Andrei, Hong, Peter
• Primary Examiner(s): BERTAGNA, ANGELA MARIE
• Application Number:
  US14/028,319
• Publication Number:
  US 20140005056A1
• Time in Patent Office: 1,163 Days
• Field of Search: None
• US Class Current: 1/1
• CPC Class Codes: B01J 19/0046 Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays synthesis methods per se C40B50/00
• CPC Class Codes: B01J 2219/00722 Nucleotides
• CPC Class Codes: C12N 15/1093 General methods of preparing gene libraries, not provided for in other subgroups
• CPC Class Codes: C12P 19/34 Polynucleotides, e.g. nucleic acids, oligoribonucleotides
• CPC Class Codes: C12Q 1/6869 Methods for sequencing
• CPC Class Codes: C12Q 1/6874 involving nucleic acid arrays, e.g. sequencing by hybridisation
• CPC Class Codes: C12Q 2521/101 DNA polymerase
• CPC Class Codes: C12Q 2521/501 Ligase
• CPC Class Codes: C12Q 2525/101 incorporating non-naturally occurring nucleotides, e.g. inosine
• CPC Class Codes: C12Q 2525/179 incorporating arbitrary or random nucleotide sequences
• CPC Class Codes: C12Q 2525/186 incorporating a non-extendable or blocking moiety
• CPC Class Codes: C12Q 2525/191 incorporating an adaptor
• CPC Class Codes: C12Q 2537/149 Sequential reactions
• CPC Class Codes: C12Q 2563/159 Microreactors, e.g. emulsion PCR or sequencing, droplet PCR, microcapsules, i.e. non-liquid containers with a range of different permeability's for different reaction components

Abstract

The present invention is directed to methods and compositions for long fragment read sequencing. The present invention encompasses methods and compositions for preparing long fragments of genomic DNA, for processing genomic DNA for long fragment read sequencing methods, as well as software and algorithms for processing and analyzing sequence data.

Claims

1. A method of analyzing genomic DNA in a sample, the method comprising:

(a) dividing the sample into a plurality of separate aliquots;

(b) amplifying fragments of the genomic DNA in the separate aliquots to produce a plurality of amplicons, wherein the amplifying is conducted with a population of dNTPs containing dNTP analogs, whereby a number of nucleotides in the amplicons are nucleotide analogs;

(c) removing nucleotide analogs incorporated into the amplicons to form gapped DNA;

(d) treating the gapped DNA such that gaps on opposite strands converge, thereby further fragmenting the genomic DNA;

(e) tagging DNA fragments in different aliquots with different oligonucleotide tags or tag combinations to form tagged fragments;

(f) combining the aliquots to produce a mixture of tagged fragments;

(g) obtaining sequence reads from tagged fragments in the mixture, wherein using the nucleotide analogs to create the gapped DNA has the effect of reducing GC bias in the sequence reads; and

(h) phasing heterozygous loci in the genomic DNA by a process that includes identifying sequence reads for DNA fragments having the same oligonucleotide tag.

2. The method of claim 1, wherein the population comprises at least two different dNTP analogs.

3. The method of claim 1, wherein the population comprises dUTP and 5-methyl dCTP.

4. The method of claim 1, wherein the separate aliquots are droplets.

21. The method of claim 1, wherein the amplifying of the genomic DNA or DNA fragments in the separate aliquots is performed before the DNA fragments are tagged with the different oligonucleotide tag or tag combinations.

5. A method of preparing genomic DNA in a sample for sequence determination, comprising:

(a) dividing the sample into a plurality of separate aliquots;

(b) amplifying DNA in the separate aliquots in the presence of a mixture of nucleotides and nucleotide analogs having a ratio of dUTP to dTTP and a ratio of 5-methyl dCTP to dCTP, thereby producing a plurality of amplicons in which 0.05% to 4% of the cytosines and 0.05% to 4% of the thymines are replaced by a nucleotide analog;

(c) contacting the amplicons with a reagent such that deoxyuracils incorporated into the amplicons are removed, leaving gaps;

(d) contacting the amplicons with a reagent such that 5-methyl cytosines incorporated into amplicons are removed, leaving gaps; and

(e) contacting the amplicons with a reagent such that gaps on opposite strands of the DNA converge, thereby creating DNA fragments.

6. A method of sequencing a sample of DNA, comprising preparing the DNA according to claim 5, and then obtaining a number of sequence reads from DNA fragments in a plurality of the aliquots.

7. The method of claim 5, the method further comprising preselecting the ratio of dUTP to dTTP and preselecting the ratio of 5-methyl dCTP to dCTP such that the blunt-ended DNA fragments produced following step (d) are between 50,000 and 1,500,000 nucleotides in length.

8. The method of claim 5, the method further comprising preselecting the ratio of dUTP to dTTP and preselecting the ratio of 5-methyl dCTP to dCTP such that the blunt-ended DNA fragments produced following step (d) are no more than about 10,000 nucleotides in length.

9. The method of claim 5, wherein the separate aliquots have a volume of less than 100 nL.

10. The method of claim 5, wherein step (b) is conducted in the presence of an additive selected from glycogen, dimethyl sulfoxide (DMSO), Extreme Thermostable Single-Stranded DNA Binding Protein (ET SSB), trimethylglycine (TMG) (betaine), and any combination thereof.

22. The method of claim 5, wherein the reagent used in step (c) includes at least one of UDG, EndoIV, and EndoVIII.

23. The method of claim 5, wherein the reagent used in step (d) includes McrBC.

24. The method of claim 5, wherein the reagent used in step (e) includes Taq polymerase or E. coli Pol 1.

11. A method for reducing GC bias when sequencing a sample of genomic DNA, wherein the sequencing comprises:

(i) dividing the sample into a plurality of separate aliquots;

(ii) amplifying fragments of the genomic DNA in the separate aliquots to produce amplicons,

(iii) combining the amplicons from a plurality of the aliquots into a mixture;

(iv) obtaining sequence reads from amplicons in the mixture; and

(v) assembling sequence information for the genomic DNA by a process that includes identifying sequence reads for fragments originating in the same aliquot;

wherein the method of reducing GC bias comprises;

(a) conducting the amplifying in step (ii) in the presence of a combination of dNTPs containing nucleotide analogs, such that some of the nucleotides incorporated into the amplicons are nucleotide analogs;

(b) removing nucleotide analogs incorporated into the amplicons to form gapped DNA; and

(c) treating the gapped DNA such that gaps on opposite strands converge, thereby producing cleaved fragments for sequencing;

wherein using the nucleotide analogs to produce the cleaved fragments has the effect of reducing GC bias in the sequencing.

12. The method of claim 11, further comprising tagging the gapped DNA in the separate aliquots such that gapped DNA in different aliquots is tagged with oligonucleotide tags having different sequences.

13. The method of claim 11, wherein step (a) is conducted in the presence of at least two different dNTP analogs.

14. The method of claim 11, wherein the step (a) is conducted in the presence of both dUTP and 5-methyl dCTP.

15. The method of claim 11, wherein the separate aliquots are droplets.

16. The method of claim 11, wherein the amplifying in step (ii) is conducted in the presence of an additive selected from glycogen, dimethyl sulfoxide (DMSO), Extreme Thermostable Single-Stranded DNA Binding Protein (ET SSB), trimethylglycine (TMG) (betaine), and any combination thereof.

17. The method of claim 16, wherein the additive or additive combination includes 0.5% to 10% DMSO.

18. The method of claim 16, wherein the additive or additive combination includes ET SSB.

19. The method of claim 16, wherein the additive or additive combination includes betaine.

20. The method of claim 11, wherein GC bias is further reduced by amplifying in step (ii) using primers with a low GC content.